Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study

Table 1

Clinical characteristics of the study participants.

Age (years)
Median (IQR)	75.0 (68.8–81.3)
Retention volume (mL)
Median (IQR)	500 (375–1000)
IPSS
Median (IQR)	26 (16–31)
IPSS-QOL
Median (IQR)	5 (5-6)
PSA (ng/mL)
Median (IQR)	5.80 (3.15–12.70)
Prostate volume (mL)
Median (IQR)	46.4 (34.9–69.6)

IQR, interquartile range; IPSS, International Prostatic Symptoms Score; IPSS-QOL, quality of life due to urinary symptoms; PSA, prostate-specific antigen.